United States · FDA National Drug Code directory
memantine hydrochloride and donepezil hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69680-183_ffe5cf41-299a-49e5-a9b8-c9048c4861fa
- Product NDC
- 69680-183
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- memantine hydrochloride and donepezil hydrochloride
- Labeler
- Vitruvias Therapeutics, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250716
- Source listing expiry
- 20261231
Source-listed ingredients
- MEMANTINE HYDROCHLORIDE — 14 mg/1
- DONEPEZIL HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69680-183-30) · 69680-183-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →